Correlation Between Denali Therapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Fate Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Fate Therapeutics.
Diversification Opportunities for Denali Therapeutics and Fate Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Denali and Fate is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Fate Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.46 times more return on investment than Fate Therapeutics. However, Denali Therapeutics is 2.17 times less risky than Fate Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 2,608 in Denali Therapeutics on September 23, 2024 and sell it today you would lose (463.00) from holding Denali Therapeutics or give up 17.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Fate Therapeutics
Performance |
Timeline |
Denali Therapeutics |
Fate Therapeutics |
Denali Therapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Fate Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Denali Therapeutics vs. Fate Therapeutics | Denali Therapeutics vs. Sana Biotechnology | Denali Therapeutics vs. Caribou Biosciences | Denali Therapeutics vs. Arcus Biosciences |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |